Zactima Phase III Trials to Start for Lung Cancer Treatment
Sun, 10 Jul 2005 06:00 PM EST
... AstraZeneca announced that it is to progress to Phase III studies with its novel oncology compound ZD6474 - now to be known by its trade name, ZACTIMATM... click link for more info. ...
Related Topics
- Lung Cancer
- Small Cell Lung Cancer
- Clinical Trials
- Cancers
- Lung Diseases & Disorders
- Metastatic Cancer
- Non-Small Cell Lung Cancer
- Brain Cancer
- Liver Cancer
- Pemetrexed for Injection
- Black Lung
- Antithrombin III
- Respiratory Diseases
- Prostate Cancer
- Treatment
- Kidney Cancer
- Pancreatic Cancer
- Esophageal Cancer
- Chemotherapy
- Stomach Cancer

Not Signed In -


